Agios Pharmaceuticals
AGIO
AGIO
219 hedge funds and large institutions have $2.55B invested in Agios Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 69 increasing their positions, 68 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.77% more ownership
Funds ownership: 106.51% → 109.28% (+2.8%)
9% more call options, than puts
Call options by funds: $85.2M | Put options by funds: $78.2M
1% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 68
Holders
219
Holding in Top 10
4
Calls
$85.2M
Puts
$78.2M
Top Buyers
| 1 | +$77.1M | |
| 2 | +$57.6M | |
| 3 | +$27.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$18.6M |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$16.5M |
Top Sellers
| 1 | -$31.8M | |
| 2 | -$23.2M | |
| 3 | -$22.2M | |
| 4 |
O
OrbiMed
New York
|
-$18.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$17.2M |
